医薬品分離＆封じ込めシステムのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Pharmaceutical Isolating and Containment Systems Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B15254 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

医薬品分離＆封じ込めシステム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の医薬品分離＆封じ込めシステムの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の医薬品分離＆封じ込めシステムの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 医薬品分離＆封じ込めシステム市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・生産用分離＆封じ込めシステム、検査用分離＆封じ込めシステムのテスト 用途別セグメントは次のように区分されます。 ・学術研究機関、製薬・バイオテクノロジー企業、その他 世界の医薬品分離＆封じ込めシステム市場の主要な市場プレーヤーは以下のとおりです。 ・SKAN、Extract Technology、Bioquell、Tofflon、Getinge、Syntegon、Comecer、ISOTECH、Weike、Azbil Telstar、Fedegari Autoclavi、Hosokawa Micron 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、医薬品分離＆封じ込めシステム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な医薬品分離＆封じ込めシステムメーカーの企業概要、2019年～2021年までの医薬品分離＆封じ込めシステムの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な医薬品分離＆封じ込めシステムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別医薬品分離＆封じ込めシステムの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの医薬品分離＆封じ込めシステムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での医薬品分離＆封じ込めシステム市場予測を収録しています。 ・第12、13、14章では、医薬品分離＆封じ込めシステムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：SKAN、Extract Technology、Bioquell、Tofflon、Getinge、Syntegon、Comecer、ISOTECH、Weike、Azbil Telstar、Fedegari Autoclavi、Hosokawa Micron ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：生産用分離＆封じ込めシステム、検査用分離＆封じ込めシステムのテスト ・用途別分析2016年-2026年：学術研究機関、製薬・バイオテクノロジー企業、その他 ・医薬品分離＆封じ込めシステムの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・医薬品分離＆封じ込めシステムのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・医薬品分離＆封じ込めシステムのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・医薬品分離＆封じ込めシステムの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・医薬品分離＆封じ込めシステムの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Pharmaceutical Isolating and Containment Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pharmaceutical Isolating and Containment Systems size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Pharmaceutical Isolating and Containment Systems market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Pharmaceutical Isolating and Containment Systems market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Production Isolating and Containment Systems
Testing Isolating and Containment Systems

Market segment by Application can be divided into
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Others

The key market players for global Pharmaceutical Isolating and Containment Systems market are listed below:
SKAN
Extract Technology
Bioquell
Tofflon
Getinge
Syntegon
Comecer
ISOTECH
Weike
Azbil Telstar
Fedegari Autoclavi
Hosokawa Micron

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pharmaceutical Isolating and Containment Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pharmaceutical Isolating and Containment Systems, with price, sales, revenue and global market share of Pharmaceutical Isolating and Containment Systems from 2019 to 2021.
Chapter 3, the Pharmaceutical Isolating and Containment Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Isolating and Containment Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pharmaceutical Isolating and Containment Systems market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pharmaceutical Isolating and Containment Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Pharmaceutical Isolating and Containment Systems Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pharmaceutical Isolating and Containment Systems Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Production Isolating and Containment Systems
1.2.3 Testing Isolating and Containment Systems
1.3 Market Analysis by Application
1.3.1 Overview: Global Pharmaceutical Isolating and Containment Systems Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Others
1.4 Global Pharmaceutical Isolating and Containment Systems Market Size & Forecast
1.4.1 Global Pharmaceutical Isolating and Containment Systems Sales in Value (2016-2026))
1.4.2 Global Pharmaceutical Isolating and Containment Systems Sales in Volume (2016-2026)
1.4.3 Global Pharmaceutical Isolating and Containment Systems Price by Type (2016-2026) & (US$/Unit)
1.5 Global Pharmaceutical Isolating and Containment Systems Production Capacity Analysis
1.5.1 Global Pharmaceutical Isolating and Containment Systems Total Production Capacity (2016-2026)
1.5.2 Global Pharmaceutical Isolating and Containment Systems Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical Isolating and Containment Systems Market Drivers
1.6.2 Pharmaceutical Isolating and Containment Systems Market Restraints
1.6.3 Pharmaceutical Isolating and Containment Systems Trends Analysis
2 Manufacturers Profiles
2.1 SKAN
2.1.1 SKAN Details
2.1.2 SKAN Major Business
2.1.3 SKAN Pharmaceutical Isolating and Containment Systems Product and Services
2.1.4 SKAN Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Extract Technology
2.2.1 Extract Technology Details
2.2.2 Extract Technology Major Business
2.2.3 Extract Technology Pharmaceutical Isolating and Containment Systems Product and Services
2.2.4 Extract Technology Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bioquell
2.3.1 Bioquell Details
2.3.2 Bioquell Major Business
2.3.3 Bioquell Pharmaceutical Isolating and Containment Systems Product and Services
2.3.4 Bioquell Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Tofflon
2.4.1 Tofflon Details
2.4.2 Tofflon Major Business
2.4.3 Tofflon Pharmaceutical Isolating and Containment Systems Product and Services
2.4.4 Tofflon Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Getinge
2.5.1 Getinge Details
2.5.2 Getinge Major Business
2.5.3 Getinge Pharmaceutical Isolating and Containment Systems Product and Services
2.5.4 Getinge Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Syntegon
2.6.1 Syntegon Details
2.6.2 Syntegon Major Business
2.6.3 Syntegon Pharmaceutical Isolating and Containment Systems Product and Services
2.6.4 Syntegon Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Comecer
2.7.1 Comecer Details
2.7.2 Comecer Major Business
2.7.3 Comecer Pharmaceutical Isolating and Containment Systems Product and Services
2.7.4 Comecer Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 ISOTECH
2.8.1 ISOTECH Details
2.8.2 ISOTECH Major Business
2.8.3 ISOTECH Pharmaceutical Isolating and Containment Systems Product and Services
2.8.4 ISOTECH Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Weike
2.9.1 Weike Details
2.9.2 Weike Major Business
2.9.3 Weike Pharmaceutical Isolating and Containment Systems Product and Services
2.9.4 Weike Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Azbil Telstar
2.10.1 Azbil Telstar Details
2.10.2 Azbil Telstar Major Business
2.10.3 Azbil Telstar Pharmaceutical Isolating and Containment Systems Product and Services
2.10.4 Azbil Telstar Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Fedegari Autoclavi
2.11.1 Fedegari Autoclavi Details
2.11.2 Fedegari Autoclavi Major Business
2.11.3 Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Product and Services
2.11.4 Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Hosokawa Micron
2.12.1 Hosokawa Micron Details
2.12.2 Hosokawa Micron Major Business
2.12.3 Hosokawa Micron Pharmaceutical Isolating and Containment Systems Product and Services
2.12.4 Hosokawa Micron Pharmaceutical Isolating and Containment Systems Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Pharmaceutical Isolating and Containment Systems Sales by Manufacturer
3.1 Global Pharmaceutical Isolating and Containment Systems Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pharmaceutical Isolating and Containment Systems Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pharmaceutical Isolating and Containment Systems
3.4 Market Concentration Rate
3.4.1 Top 3 Pharmaceutical Isolating and Containment Systems Manufacturer Market Share
3.4.2 Top 6 Pharmaceutical Isolating and Containment Systems Manufacturer Market Share
3.5 Global Pharmaceutical Isolating and Containment Systems Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pharmaceutical Isolating and Containment Systems Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pharmaceutical Isolating and Containment Systems Market Size by Region
4.1.1 Global Pharmaceutical Isolating and Containment Systems Sales in Volume by Region (2016-2026)
4.1.2 Global Pharmaceutical Isolating and Containment Systems Revenue by Region (2016-2026)
4.2 North America Pharmaceutical Isolating and Containment Systems Revenue (2016-2026)
4.3 Europe Pharmaceutical Isolating and Containment Systems Revenue (2016-2026)
4.4 Asia-Pacific Pharmaceutical Isolating and Containment Systems Revenue (2016-2026)
4.5 South America Pharmaceutical Isolating and Containment Systems Revenue (2016-2026)
4.6 Middle East and Africa Pharmaceutical Isolating and Containment Systems Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pharmaceutical Isolating and Containment Systems Sales in Volume by Type (2016-2026)
5.2 Global Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2026)
5.3 Global Pharmaceutical Isolating and Containment Systems Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pharmaceutical Isolating and Containment Systems Sales in Volume by Application (2016-2026)
6.2 Global Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2026)
6.3 Global Pharmaceutical Isolating and Containment Systems Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2026)
7.2 North America Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2026)
7.3 North America Pharmaceutical Isolating and Containment Systems Market Size by Country
7.3.1 North America Pharmaceutical Isolating and Containment Systems Sales in Volume by Country (2016-2026)
7.3.2 North America Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2026)
8.2 Europe Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2026)
8.3 Europe Pharmaceutical Isolating and Containment Systems Market Size by Country
8.3.1 Europe Pharmaceutical Isolating and Containment Systems Sales in Volume by Country (2016-2026)
8.3.2 Europe Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2026)
9.2 Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2026)
9.3 Asia-Pacific Pharmaceutical Isolating and Containment Systems Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pharmaceutical Isolating and Containment Systems Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2026)
10.2 South America Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2026)
10.3 South America Pharmaceutical Isolating and Containment Systems Market Size by Country
10.3.1 South America Pharmaceutical Isolating and Containment Systems Sales in Volume by Country (2016-2026)
10.3.2 South America Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2026)
11.2 Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2026)
11.3 Middle East & Africa Pharmaceutical Isolating and Containment Systems Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pharmaceutical Isolating and Containment Systems Typical Distributors
12.3 Pharmaceutical Isolating and Containment Systems Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Pharmaceutical Isolating and Containment Systems Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pharmaceutical Isolating and Containment Systems Revenue by Application, (USD Million), 2021-2026
Table 3. SKAN Basic Information, Manufacturing Base and Competitors
Table 4. SKAN Major Business
Table 5. SKAN Pharmaceutical Isolating and Containment Systems Product and Services
Table 6. SKAN Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Extract Technology Basic Information, Manufacturing Base and Competitors
Table 8. Extract Technology Major Business
Table 9. Extract Technology Pharmaceutical Isolating and Containment Systems Product and Services
Table 10. Extract Technology Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bioquell Basic Information, Manufacturing Base and Competitors
Table 12. Bioquell Major Business
Table 13. Bioquell Pharmaceutical Isolating and Containment Systems Product and Services
Table 14. Bioquell Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Tofflon Basic Information, Manufacturing Base and Competitors
Table 16. Tofflon Major Business
Table 17. Tofflon Pharmaceutical Isolating and Containment Systems Product and Services
Table 18. Tofflon Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Getinge Basic Information, Manufacturing Base and Competitors
Table 20. Getinge Major Business
Table 21. Getinge Pharmaceutical Isolating and Containment Systems Product and Services
Table 22. Getinge Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Syntegon Basic Information, Manufacturing Base and Competitors
Table 24. Syntegon Major Business
Table 25. Syntegon Pharmaceutical Isolating and Containment Systems Product and Services
Table 26. Syntegon Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Comecer Basic Information, Manufacturing Base and Competitors
Table 28. Comecer Major Business
Table 29. Comecer Pharmaceutical Isolating and Containment Systems Product and Services
Table 30. Comecer Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. ISOTECH Basic Information, Manufacturing Base and Competitors
Table 32. ISOTECH Major Business
Table 33. ISOTECH Pharmaceutical Isolating and Containment Systems Product and Services
Table 34. ISOTECH Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Weike Basic Information, Manufacturing Base and Competitors
Table 36. Weike Major Business
Table 37. Weike Pharmaceutical Isolating and Containment Systems Product and Services
Table 38. Weike Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Azbil Telstar Basic Information, Manufacturing Base and Competitors
Table 40. Azbil Telstar Major Business
Table 41. Azbil Telstar Pharmaceutical Isolating and Containment Systems Product and Services
Table 42. Azbil Telstar Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Fedegari Autoclavi Basic Information, Manufacturing Base and Competitors
Table 44. Fedegari Autoclavi Major Business
Table 45. Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Product and Services
Table 46. Fedegari Autoclavi Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Hosokawa Micron Basic Information, Manufacturing Base and Competitors
Table 48. Hosokawa Micron Major Business
Table 49. Hosokawa Micron Pharmaceutical Isolating and Containment Systems Product and Services
Table 50. Hosokawa Micron Pharmaceutical Isolating and Containment Systems Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Pharmaceutical Isolating and Containment Systems Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Pharmaceutical Isolating and Containment Systems Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Pharmaceutical Isolating and Containment Systems, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Pharmaceutical Isolating and Containment Systems Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Pharmaceutical Isolating and Containment Systems Production Site of Key Manufacturer
Table 56. Pharmaceutical Isolating and Containment Systems New Entrant and Capacity Expansion Plans
Table 57. Pharmaceutical Isolating and Containment Systems Mergers & Acquisitions in the Past Five Years
Table 58. Global Pharmaceutical Isolating and Containment Systems Sales by Region (2016-2021e) & (K Units)
Table 59. Global Pharmaceutical Isolating and Containment Systems Sales by Region (2021-2026) & (K Units)
Table 60. Global Pharmaceutical Isolating and Containment Systems Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Pharmaceutical Isolating and Containment Systems Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021e) & (K Units)
Table 63. Global Pharmaceutical Isolating and Containment Systems Sales by Type (2021-2026) & (K Units)
Table 64. Global Pharmaceutical Isolating and Containment Systems Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Pharmaceutical Isolating and Containment Systems Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Pharmaceutical Isolating and Containment Systems Price by Type (2016-2021e) & (US$/Unit)
Table 67. Global Pharmaceutical Isolating and Containment Systems Price by Type (2021-2026) & (US$/Unit)
Table 68. Global Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021e) & (K Units)
Table 69. Global Pharmaceutical Isolating and Containment Systems Sales by Application (2021-2026) & (K Units)
Table 70. Global Pharmaceutical Isolating and Containment Systems Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Pharmaceutical Isolating and Containment Systems Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Pharmaceutical Isolating and Containment Systems Price by Application (2016-2021e) & (US$/Unit)
Table 73. Global Pharmaceutical Isolating and Containment Systems Price by Application (2021-2026) & (US$/Unit)
Table 74. North America Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2021e) & (K Units)
Table 75. North America Pharmaceutical Isolating and Containment Systems Sales by Country (2021-2026) & (K Units)
Table 76. North America Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Pharmaceutical Isolating and Containment Systems Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021e) & (K Units)
Table 79. North America Pharmaceutical Isolating and Containment Systems Sales by Type (2021-2026) & (K Units)
Table 80. North America Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021e) & (K Units)
Table 81. North America Pharmaceutical Isolating and Containment Systems Sales by Application (2021-2026) & (K Units)
Table 82. Europe Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2021e) & (K Units)
Table 83. Europe Pharmaceutical Isolating and Containment Systems Sales by Country (2021-2026) & (K Units)
Table 84. Europe Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Pharmaceutical Isolating and Containment Systems Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021e) & (K Units)
Table 87. Europe Pharmaceutical Isolating and Containment Systems Sales by Type (2021-2026) & (K Units)
Table 88. Europe Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021e) & (K Units)
Table 89. Europe Pharmaceutical Isolating and Containment Systems Sales by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales by Region (2016-2021e) & (K Units)
Table 91. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific Pharmaceutical Isolating and Containment Systems Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Pharmaceutical Isolating and Containment Systems Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021e) & (K Units)
Table 95. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales by Type (2021-2026) & (K Units)
Table 96. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021e) & (K Units)
Table 97. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales by Application (2021-2026) & (K Units)
Table 98. South America Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2021e) & (K Units)
Table 99. South America Pharmaceutical Isolating and Containment Systems Sales by Country (2021-2026) & (K Units)
Table 100. South America Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Pharmaceutical Isolating and Containment Systems Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021e) & (K Units)
Table 103. South America Pharmaceutical Isolating and Containment Systems Sales by Type (2021-2026) & (K Units)
Table 104. South America Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021e) & (K Units)
Table 105. South America Pharmaceutical Isolating and Containment Systems Sales by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Country (2016-2021e) & (K Units)
Table 107. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Type (2016-2021e) & (K Units)
Table 111. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Type (2021-2026) & (K Units)
Table 112. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Application (2016-2021e) & (K Units)
Table 113. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales by Application (2021-2026) & (K Units)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Pharmaceutical Isolating and Containment Systems Typical Distributors
Table 117. Pharmaceutical Isolating and Containment Systems Typical Customers
List of Figures
Figure 1. Pharmaceutical Isolating and Containment Systems Picture
Figure 2. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Type in 2020
Figure 3. Production Isolating and Containment Systems
Figure 4. Testing Isolating and Containment Systems
Figure 5. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Application in 2020
Figure 6. Academic and Research Institutes
Figure 7. Pharmaceutical and Biotechnology Companies
Figure 8. Others
Figure 9. Global Pharmaceutical Isolating and Containment Systems Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Pharmaceutical Isolating and Containment Systems Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Pharmaceutical Isolating and Containment Systems Sales (2016-2026) & (K Units)
Figure 12. Global Pharmaceutical Isolating and Containment Systems Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global Pharmaceutical Isolating and Containment Systems Production Capacity (2016-2026) & (K Units)
Figure 14. Global Pharmaceutical Isolating and Containment Systems Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Pharmaceutical Isolating and Containment Systems Market Drivers
Figure 16. Pharmaceutical Isolating and Containment Systems Market Restraints
Figure 17. Pharmaceutical Isolating and Containment Systems Market Trends
Figure 18. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Manufacturer in 2020
Figure 19. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Manufacturer in 2020
Figure 20. Pharmaceutical Isolating and Containment Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Pharmaceutical Isolating and Containment Systems Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Pharmaceutical Isolating and Containment Systems Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Region (2016-2026)
Figure 24. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Region (2016-2026)
Figure 25. North America Pharmaceutical Isolating and Containment Systems Revenue (2016-2026) & (USD Million)
Figure 26. Europe Pharmaceutical Isolating and Containment Systems Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Pharmaceutical Isolating and Containment Systems Revenue (2016-2026) & (USD Million)
Figure 28. South America Pharmaceutical Isolating and Containment Systems Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue (2016-2026) & (USD Million)
Figure 30. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2026)
Figure 31. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Type (2016-2026)
Figure 32. Global Pharmaceutical Isolating and Containment Systems Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2026)
Figure 34. Global Pharmaceutical Isolating and Containment Systems Revenue Market Share by Application (2016-2026)
Figure 35. Global Pharmaceutical Isolating and Containment Systems Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2026)
Figure 37. North America Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2026)
Figure 38. North America Pharmaceutical Isolating and Containment Systems Sales Market Share by Country (2016-2026)
Figure 39. North America Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country (2016-2026)
Figure 40. United States Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2026)
Figure 44. Europe Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2026)
Figure 45. Europe Pharmaceutical Isolating and Containment Systems Sales Market Share by Country (2016-2026)
Figure 46. Europe Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country (2016-2026)
Figure 47. Germany Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Pharmaceutical Isolating and Containment Systems Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Pharmaceutical Isolating and Containment Systems Revenue Market Share by Region (2016-2026)
Figure 56. China Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2026)
Figure 63. South America Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2026)
Figure 64. South America Pharmaceutical Isolating and Containment Systems Sales Market Share by Country (2016-2026)
Figure 65. South America Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Pharmaceutical Isolating and Containment Systems Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Pharmaceutical Isolating and Containment Systems Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Pharmaceutical Isolating and Containment Systems Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---